Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Pediatr Infect Dis J ; 26(5): 428-31, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17468654

RESUMO

BACKGROUND: The long-term neurologic sequelae of childhood tuberculous meningitis (TBM) mainly result from ischemia owing to cerebral vasculitis. Deep vein thrombosis occurs in adults with pulmonary tuberculosis owing to hypercoaguability. The present study aimed to investigate coagulation status during acute childhood TBM. METHODS: Coagulation status, including the natural anticoagulants, antithrombin, protein C and protein S; procoagulant FVIII; fibrinolytic factors, tissue plasminogen activator and plasminogen activator inhibitor-1 (PAI-1) as well as anticardiolipin antibodies (ACA), was determined in 16 children with TBM before and during treatment. RESULTS: A prothrombotic profile was found as expressed by a decrease of anticoagulant (protein S) and increase of the procoagulant (factor VIII) activity. Raised PAI-1 and normal tissue plasminogen activator values indicated deficient fibrinolysis. This hypercoagulable state was more pronounced in stage 3 patients than in stage 2 patients. The bleeding time on admission ranged from 1.2 to 10 minutes [mean 4.2 minutes]. The mean platelet count on admission was 577.9 +/- 188.6 x 10/L and increased further during the course of the treatment. CONCLUSIONS: The hypercoagulable state in childhood TBM is comparable to that described in adults with pulmonary tuberculosis and may further increase the risk for infarction. Therapeutic measures that reduce the risk for thrombosis could therefore be potentially beneficial in childhood TBM.


Assuntos
Coagulação Sanguínea , Fibrinólise , Tuberculose Meníngea/sangue , Aspirina/uso terapêutico , Criança , Pré-Escolar , Humanos , Lactente , Contagem de Plaquetas , Terapia Trombolítica
2.
Ann N Y Acad Sci ; 957: 337-40, 2002 May.
Artigo em Inglês | MEDLINE | ID: mdl-12074993

RESUMO

We investigated the in vivo effects of regular consumption of red and white wine on the serum lipid profile, plasma plasminogen activator-1, homocysteine levels, and total antioxidant status. This study confirmed that moderate consumption of wine, red more than white, exerts cardioprotective effects through beneficial changes in lipid profiles and plasma total antioxidant status.


Assuntos
Antioxidantes/análise , Cardiotônicos/farmacologia , Homocisteína/sangue , Lipídeos/sangue , Inibidor 1 de Ativador de Plasminogênio/sangue , Vinho , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
3.
Ann N Y Acad Sci ; 957: 329-32, 2002 May.
Artigo em Inglês | MEDLINE | ID: mdl-12074991

RESUMO

We compared the in vivo effect of red vs. white wine consumption on platelet aggregation, responsiveness and membrane viscosity, plasma total antioxidant status, thromboxane B(2) levels, and fibrinolysis. Diet and red wine had a synergistic effect in decreasing platelet aggregation. Red wine did not have a significantly more favorable effect on the fibrinolytic factors than white wine. The reduction in platelet membrane viscosity after red wine, which could contribute to the protective antithrombotic role of red wine, needs further explanation.


Assuntos
Consumo de Bebidas Alcoólicas , Plaquetas/efeitos dos fármacos , Plaquetas/fisiologia , Fibrinolíticos/farmacologia , Hemostasia/efeitos dos fármacos , Vinho , Adulto , Antioxidantes/análise , Membrana Celular/efeitos dos fármacos , Membrana Celular/fisiologia , Feminino , Fibrinogênio/análise , Fibrinólise/efeitos dos fármacos , Humanos , Masculino , Pessoa de Meia-Idade , Agregação Plaquetária/efeitos dos fármacos , Viscosidade/efeitos dos fármacos
4.
Metab Brain Dis ; 21(2-3): 109-20, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16850257

RESUMO

Caucasian South African patients with multiple sclerosis (MS) were screened for the most common hereditary haemochromatosis (HH) mutations, H63D and C282Y, in order to determine the impact of iron overload on clinical outcome of MS. DNA screening for mutations H63D and C282Y in 118 apparently unrelated MS patients did not reveal significant differences in allele frequencies in comparison with a control group from the same population. Of 17 MS patients heterozygous for C282Y, 3 had below normal and none had above normal transferrin saturation levels. One of the index MS patients, and subsequently also her sister who also has MS, tested positive for two copies of mutation C282Y. Determination of iron status revealed high serum ferritin and transferrin saturation levels in both patients. However, the index patient, being unaware of her C282Y status, had received treatment for iron deficiency in the past and her MS symptoms were less severe than those of her sister who has been wheelchair bound for the past 12 years and who did not take iron supplements. Lack of clinical manifestation of HH without any signs of organ damage in the C282Y homozygous MS patients is in accordance with a role of iron dysregulation in the aetiology of MS.


Assuntos
Hemocromatose/sangue , Hemocromatose/genética , Esclerose Múltipla/sangue , Esclerose Múltipla/genética , Adulto , Idoso , Alelos , Contagem de Células Sanguíneas , DNA/genética , Análise Mutacional de DNA , Suplementos Nutricionais , Feminino , Ferritinas/sangue , Frequência do Gene , Genótipo , Hemocromatose/complicações , Humanos , Ferro/metabolismo , Ferro/uso terapêutico , Masculino , Pessoa de Meia-Idade , Esclerose Múltipla/complicações , Mutação/fisiologia , Linhagem , Fenótipo , África do Sul , Transferrina/metabolismo , População Branca
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA